Objectives: First, we sought to assess the frequency of incidental extra-cardiac findings (IEF) found in a consecutive series of clinical Cardiac MR scans. Second, we compared the 3 clinically used HASTE acquisition protocols in this context. Third, we determined the impact of the three different HASTE protocols on acquisition time and image quality.
INTRODUCTION:
Cardiac magnetic resonance (CMR) is now an established imaging modality with well described clinical indications 1 and appropriateness criteria 2 .
In addition to the heart, a typical CMR examination will also image adjacent thoracic and abdominal structures. Indeed most, but not all, centres initially perform gradient echo "scout"-imaging of several slices in coronal, saggital and axial views followed by axial imaging of the entire chest, conventionally using half fourier turbo spin echo imaging (e.g. HASTE). Consequently, findings incidental to the cardiac examination may be encountered some of which may be clinically relevant.
Although well described in the computed tomography (CT) literature [3] [4] [5] [6] [7] there is paucity of data regarding the frequency and clinical impact of incidental extra-cardiac findings (IEF) discovered during routine CMR.
The few studies 5, 8, 9 and preliminary reports 10, 11 available to date demonstrate considerable variability, with IEF rates ranging from 7.6% to 81%, and indicate unsurprisingly, that the prevalence of IEF is dependent on multiple factors, not least the population studied, the image sequences applied and the definitions utilised to classify and categorise IEF. Furthermore, it is unclear if the various methods of performing axial HASTE sequences (i.e breath-hold (BH), free breathing (FB), or diaphragmatic navigated (NAV)) impact on the frequency of detecting IEF. In the current study we sought to assess the frequency of IEF in consecutive patients referred for clinically indicated CMR, in an NHS tertiary care setting. We also aimed to determine the impact of the 3 most commonly applied HASTE acquisition protocols on the frequency of IEF, as well as on image acquisition time and image quality.
METHODS:
The study was planned in Whilst there was variability in case load amongst the reporting physicians, their relative reporting contributions did not change between the HASTE groups.
Furthermore, pleural effusions and/or ascites co-existing with significant ventricular impairment were in contrast to some previous studies not classified as IEF.
CMR:
All clinical CMR studies were vetted and coded by a single Consultant (MS) and for auditing purpose grouped in to one of 8 clinical indication groups (UK national MRI codes MCORV = Cardiac Ventriculogram and MCVVS = LV volume study were grouped together). Also, as we did not perform coronary artery imaging in isolation, we decided for audit purposes to classify MACOA (= MRA coronary arteries) as either a ventricular function study if no contrast was administered, or as a MCVIA (viability study) if prior contrast administration took place (in which case "late enhancement" imaging was always performed additionally).
All scans were performed according to locally agreed scanning protocols, tailored where necessary to the individual patient. These were largely based on standardised protocols recommended by the Society of Cardiac Magnetic Resonance (SCMR). As a minimum all studies included 3 localising single shot steady state sequences in 3 orthogonal planes followed by one of three HASTE protocols (see below), assessment of left and right ventricular function by means of breath hold cine steady state free precession (SSFP) sequences, predominantly retrospectively gated but triggered in the presence off significant arrhythmia. Additional sequences, were performed as clinically indicated. Eighty nine percent of patients received 0.1 to 0.2mmol/kg of intravenous gadolinium either as dimeglumine gadopenetetate (Magnevist®, Bayer Schering Pharma), Gadobutrol (Gadovist®, Bayer Schering Pharma), or Gadobenate® dimeglumine (MultiHance, Bracco).
Group 1; Axial breath hold HASTE (BH)
Axial multi-slice HASTE sequence was acquired from the top of the aortic arch to the diaphragm. The field of view (FOV) chosen was dependant on both patient size and shape and typically ranged from 340mm x 233mm to 390mm x 344mm. Base resolution and phase resolution were 256 and 59% respectively. Slice thickness and slice gap were 8mm and 2mm respectively. This resulted in a spatial resolution typically ranging from 2.3mm x 1.3mm x 8mm to 2.5mm x 1.5mm x 8mm. In the current study therefore, spatial resolution, was predominantly affected by the patientssize and shape rather than a result of the HASTE modality chosen. 
RESULTS

A)
A total of 714 studies were included in the analysis, split evenly between each cohort.
Demographic characteristics are shown in table 1. Group 3 (NAV) had a somewhat greater proportion of male subjects, although age distribution and BSA remained consistent. An analysis of the clinical indications for the study cohort is displayed in figure 1 Valvular function study
Rest perfusion study From the 714 patients scanned, a total of 180 IEFs were discovered in 162 patients.
This gives an overall prevalence of IEFs in the study of 25.2%, affecting 22.7% of patients scanned.
As outlined above, these findings were further characterised into those perceived as clinically significant or 'major', and those considered insignificant or 'minor'. Eightyeight extra-cardiac findings of minor and ninety-two of major significance were reported (see tables 3 + 4). Seven patients (1.0%) were diagnosed with more than one IEF.
Highly significant Findings:
Amongst the major IEF 8 (1.1% ) findings were considered highly significant including one bronchio-alveolar carcinoma stage 1B, 2 cases of florid pulmonary sarcoidosis in patients presenting with VT and "structurally normal hearts" on Echo, one case of pulmonary aspergillosis, 2 cases of advanced pulmonary fibrosis, one ascending thoracic aortic aneurysm (6.6cm) requiring surgery, in a patients with atypical chest pains, and a case of iatrogenic liver haemorrhage following placement of a pericardial drain.
No significant difference was found between each of the groups when analysed for the total extra-cardiac findings identified, both minor and major. 
DISCUSSION:
The literature describing the prevalence of IEF during cross-sectional cardiac imaging is predominated by publications based on cardiac CT. In contrast there is a paucity of data characterising the prevalence and clinical significance of IEF on CMR, especially in a pure clinical setting.
What the current study adds in the context of previous publications on IEF:
The present study is to our knowledge the second largest consecutive series reporting the prevalence of (previously unknown) IEF in clinically indicated CMR studies. In keeping with the cardiac CT literature (~21% prevalence) our study found that the overall detection rate of IEF on clinically indicated CMR is relatively high (22.7%).
Interestingly, our pick up rate was almost identical to a preliminary report of identical size also performed within the UK-NHS setting 11 . The group from the London Chest
Hospital found, in a slightly older population (61.3 ± 15years, range 16-86 years, 67% male), IEF in 218 (24%) out of 714 patients. These pathologies included renal cysts (9%), aortic pathology (3%), lung collapse/consolidation (2%), liver cysts (2%), lung mass (1%). They also found 2 cases of mediastinal masses, 1 mediastinal lymphadenopathy, 6 increased signal from the hila, a single renal mass, and one large hiatus hernia. In contrast with these 2 UK based CMR studies, both reporting comparable detection rates to that of cardiac CT literature, the so far largest published US based study by Chan et al 8 concluded that non-cardiac pathology is uncommonly reported. In their cohort (1534 patients, 62%male, age 50±15years) 116 studies (7.6%) had at least one non-cardiac finding of which 48 (3.1%) reports were deemed to demonstrate major and 70 (4.6%) minor findings.
Major findings were; lymphadenopathy (n=22 / 40% of major findings), Lung abnormalities (encompassing nodules, masses and infiltrates; n=19 / 35%),
Mediastinal masses (n=6 / 11%), Breast lesion (n=4 / 7%), Ascites (n=3 / 5%), soft tissue mass (n=1 / 2%). Minor findings were: Pleural effusion (n=30 /40%), benign liver cyst (n=15 / 20%), renal cysts (n=14 / 19%) ), Hiatus Hernia (n=7 / 9%), diaphragmatic abnormality (n=2 / 3%), Splenic abnormality (n=2 / 3%), paraspinal lipoma (n=2 /3%), anomalous vasculature non-cardiac (n=2 / 3%).
Importantly only 8 findings in 6 reports (0.4%) of 1534 reports were ultimately deemed to be new and clinically significant. Of note, not unexpected, the age of those with clinically significant non-cardiac pathology was greater (54±16).
Why these (apparent) discrepancies ?
The few studies 5, 8, 9 and preliminary reports 10 available demonstrate considerable variability in IEF diagnosis with rates ranging from 7.6% (0.4% for major findings) to 81% (17%) and indicate that, not surprisingly, the prevalence of IEF is dependent on multiple factors including the cohort studied, the "clinical setting", the sequences However, whilst partly coming to different conclusions with respect to the frequency of IEF, the overriding commonality between the current study and both above detailed studies, and in fact most of the published literature, is that highly significant findings 
What is the impact of the sequences used ?
A recent meta-analysis investigating the prevalence of incidental findings on magnetic resonance imaging (MRI) of the brain found unsurprisingly that sequences applied and sequence resolution were important determinant of the frequency with which IEF where identified. The current study is the first to compare three different clinically utilised HASTE protocols with respect to the frequency of IEF, image quality and acquisition time and found no significant differences with respect to the IEF detection rate. Whilst the FB HASTE (Group 2) was acquired significantly faster than the two other acquisition protocols the overall time saving (of 36 or 51 seconds respectively) was small (on the background of an average study length of 43 minutes) and occurred against a significant trade off in image quality.
Should one alter protocols during scanning to address IEF ?
This important question off course only arises if the IEF is actually identified during the acquisition of the study which will be affected by the local set-up with respect to physician supervised or unsupervised study acquisition. However, even if detected during the acquisition one must consider to what degree additional sequences performed to evaluate the IEF further would impact on the workflow within a unit.
Equally important, one must not ignore the possibility that the deviation (in particular if lengthy) from the original protocol may detrimentally effect the likelihood of answering the original clinical question posed. In this light whilst minor changes to cover the IEF with further slices/sequences may be appropriate more significant changes to the protocol may not be desirable as dedicated specialised sequences, and or contrast and expertise may be required, and /or alternative imaging modality may be more appropriate and / or cost effective.
14 The true significance of IEF?
Beyond the medico-legal aspects, the true clinical relevance probably more likely relates to the fact that a number of IEF may actually account for patient symptoms and thereby at least partly negate the originally entertained differential diagnosis.
Common examples in support of this are lung pathology such as atelectasis, Emphysema, pleural effusions, pleural and interstitial lung diseases causing shortness of breath. Equally important IEF are not infrequently a clue to either a symptom relevant co-morbidity or again intimately related to the patients presenting problems.
Examples in the current study are the patients presenting with VT in the setting of pulmonary sarcoidosis. Furthermore, IEF can provide indirect explanation for cardiac pathology such as abnormal pulmonary venous drainage contributing to SOB or coarctation, causing increased afterload and driving hypertension, leading to LVH, diastolic dysfunction and breathlessness.
Also, a range of IEF, whilst unrelated to a subjects symptoms and at the time of diagnosis of no immediate clinical significance may become highly relevant during the patients future diagnostic workup and potential subsequent treatment and therefore should be documented and communicated in a way that the benefit of this information is not subsequently lost. Examples of such cases are the finding of vascular abnormalities such as interrupted IVC or retro-oesophageal course of a right subclavian artery, both highly relevant for potential future cardiac catheterisation.
Finally, it is intuitive to assume that in individual circumstances action taken based on the detection of an IEF, e.g. such as the lung malignancies found in the current study, will improve outcome.
Study limitations:
Overall study and subgroup size was only moderate. However, this work is still the second largest published series and even our sub-groups are larger than most currently published work in this field. Despite prospective study design, report analysis for IEF reports (not images!) and review of follow on investigations and therapy was retrospective and limited to medical and electronic records of in-house patients.
Furthermore, patients were not randomised to one of the HASTE groups but for organisational reasons scanned in subsequent cohorts with the inherent risk of temporal bias. With respect to this care was given that avoid protocol changes and unchanged relative reporting contribution amongst the 3 Consultant during the study period. Most importantly, like with all previous work in this field the definition of minor and major criteria, also pre-specified and in line with the subsequently published 210 Expert Consensus on Coronary computed Tomographic angiography 12 , remains a subjective one and at least minor variations in weighting of IEF, e.g. if simple hepatic, even if multiple, and / or renal cysts are mentioned in a report can not be excluded.
Conclusions
Overall, IEF are common and require follow or additional investigations in a substantial minority of cases. However, the overall incidence of highly significant findings in the current study was low (~1%) and very similar to that found in the CT literature. Furthermore, there appears to be no substantial difference in the frequency of incidental extra-cardiac findings between the 3 clinically applied HASTE protocols. Whilst the FB HASTE technique is statistically significantly faster than BH and NAV HASTE the absolute time saving is small and probably out-weight by the resulting lesser image quality. Image A: HASTE images in a 35 year old man being investigated for sustained ventricular tachycardia. The three axial cuts from the upper thorax demonstrate right supraclavicular and bilateral upper paratracheal lymphadenopathy (yellow arrows). The diagnosis of sarcoidosis was subsequently confirmed with transbronchial biopsy. There was no evidence of localised myocardial oedema on T2 weighted imaging nor localised hyperenhancement on myocardial delayed gadolinium imaging. Image B: Axial HASTE image at the level of the upper arch demonstrating bilateral pulmonary parenchymal high signal within the posterior upper lobes (yellow arrows) in a patient presenting with non-sustained VT and subsequently diagnosed with sarcoidosis. Again the patient had no evidence of localised hyperenhancement on myocardial delayed gadolinium imaging. Image C: Phase sensitive inversion recovery (PSIR) delayed Gadolinium image of a patient investigated for heart failure symptoms. The image shows multiple areas of localised hyperenhancement (yellow arrows) affecting both ventricles. The patient also had mild mediastinal lymphadenopathy and subsequent mediastinal lymph node biopsy confirmed the diagnosis of sarcoidosis. 
